Understanding the salinity stress on plant and developing sustainable management strategies mediated salt-tolerant plant growth-promoting rhizobacteria and CRISPR/Cas9

ABSTRACT

Soil salinity is a worldwide concern that decreases plant growth performance in agricultural fields and contributes to food scarcity. Salt stressors have adverse impacts on the plant’s ionic, osmotic, and oxidative balance, as well as numerous physiological functions. Plants have a variety of coping strategies to deal with salt stress, including osmosensing, osmoregulation, ion-homeostasis, increased antioxidant synthesis, and so on. Not only does salt stress cause oxidative stress but also many types of stress do as well, thus plants have an effective antioxidant system to battle the negative effects of excessive reactive oxygen species produced as a result of stress. Rising salinity in the agricultural field affects crop productivity and plant development considerably; nevertheless, plants have a well-known copying mechanism that shields them from salt stress by facilitated production of secondary metabolites, antioxidants, ionhomeostasis, ABAbiosynthesis, and so on. To address this problem, various environment-friendly solutions such as salt-tolerant plant growth-promoting rhizobacteria, eco-friendly additives, and foliar applications of osmoprotectants/antioxidants are urgently needed. CRISPR/Cas9, a new genetic scissor, has recently been discovered to be an efficient approach for reducing salt stress in plants growing in saline soil. Understanding the processes underlying these physiological and biochemical responses to salt stress might lead to more effective crop yield control measures in the future. In order to address this information, the current review discusses recent advances in plant stress mechanisms against salinity stress-mediated antioxidant systems, as well as the development of appropriate long-term strategies for plant growth mediated by CRISPR/Cas9 techniques under salinity stress.

KEYWORDS:

• Plant stress
• Salinity
• PGPR
• Crispr/Cas9
• Osmoprotectants

Author contributions

SKU, PKC, MT, DK: Conceptualization and Visualization of the present review and writing the original draft. SKU, PKC, MT, and DK: designed the figures and tables. RS, SKS and PD contributed to restructuring the review.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported that there is no funding associated with the work featured in this article